98%
921
2 minutes
20
Objective: ARIEL3 (NCT01968213) is a placebo-controlled randomized trial of the poly(ADP-ribose) polymerase inhibitor rucaparib as maintenance treatment in patients with recurrent high-grade ovarian carcinoma who responded to their latest line of platinum therapy. Rucaparib improved progression-free survival across all predefined subgroups. Here, we present an exploratory analysis of clinical and molecular characteristics associated with exceptional benefit from rucaparib.
Methods: Patients were randomized 2:1 to receive rucaparib 600 mg twice daily or placebo. Molecular features (genomic alterations, BRCA1 promoter methylation) and baseline clinical characteristics were evaluated for association with exceptional benefit (progression-free survival ≥2 years) versus progression on first scan (short-term subgroup) and other efficacy outcomes.
Results: Rucaparib treatment was significantly associated with exceptional benefit compared with placebo: 79/375 (21.1%) vs 4/189 (2.1%), respectively (p < 0.0001). Exceptional benefit was more frequent among patients with favorable baseline clinical characteristics and with carcinomas harboring molecular evidence of homologous recombination deficiency (HRD). A comparison between patients who derived exceptional benefit from rucaparib and those in the short-term subgroup revealed both clinical markers (no measurable disease at baseline, complete response to latest platinum, longer penultimate platinum-free interval) and molecular markers (BRCA1, BRCA2, RAD51C, and RAD51D alterations and genome-wide loss of heterozygosity) significantly associated with exceptional benefit.
Conclusions: Exceptional benefit in ARIEL3 was more common in, but not exclusive to, patients with favorable clinical characteristics or molecular features associated with HRD. Our results suggest that rucaparib can deliver exceptional benefit to a diverse set of patients with recurrent high-grade ovarian carcinoma.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339359 | PMC |
http://dx.doi.org/10.1016/j.ygyno.2022.08.021 | DOI Listing |
Angew Chem Int Ed Engl
September 2025
Center for Clean Energy Technology, School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales, 2007, Australia.
The coupling of electrocatalytic CO reduction (ECR) and methanol oxidation reaction (MOR) presents a promising strategy for simultaneous cogeneration of formic acid (FA) at both cathode and anode. However, sluggish kinetics, low selectivity and efficiency hinder practical application. Herein, we demonstrate an integrated ECR||MOR system employing CuBi cathode and NiCo anode for energy-efficient FA cogeneration.
View Article and Find Full Text PDFACS Appl Mater Interfaces
September 2025
The State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics Chinese Academy of Science, Shanghai 200050, P. R. China.
The development of solid-state lithium metal batteries (SSLBs) faces challenges like high interfacial resistance, volume fluctuations, and lithium dendrite growth. This work employs a template method to in situ construct a three-dimensional (3D) metallic nanonetwork with mixed ionic/electronic conductivity (MIEC) on Ta-doped LLZTO solid electrolyte. This structure not only remains stably anchored at the LLZTO interface but also exhibits excellent electronic conductivity, enabling a more uniform electron distribution across the heterogeneous interface.
View Article and Find Full Text PDFAppl Neuropsychol Child
September 2025
Department of Psychology and Education of Exceptional Children, Faculty of Psychology and Educational Sciences, Allameh Tabataba'i University, Tehran, Iran.
Objective: This study aimed to evaluate the effectiveness of vestibular exercises in enhancing auditory memory and auditory discrimination in high-functioning children diagnosed with autism spectrum disorder (ASD).
Methods: Employing a quasi-experimental pretest-posttest design, the study recruited 20 children aged 6-8 years with confirmed diagnoses of high-functioning autism from psychology clinics in Tehran in 2024, using convenience sampling. Participants were randomly assigned to either an experimental group (n = 10), which underwent vestibular training, or a control group (n = 10) that received no intervention.
Small
September 2025
Key Laboratory of Bioinorganic and Synthetic Chemistry of Ministry of Education, Lehn Institute of Functional Materials, GBRCE for Functional Molecular Engineering, School of Chemistry, IGCME, Sun Yat-Sen University, Guangzhou, 510275, China.
Methylammonium lead bromide perovskite (MAPbBr) quantum dots (QDs) have emerged as promising candidates for next-generation optoelectronic applications owing to their exceptional photoluminescent properties. However, their practical applications face significant challenges due to inherent instability issues. Herein, a solvent-induced in situ crystallization method is presented to encapsulate MAPbBr QDs within a crosslinked (cl-) polymethyl methacrylate (PMMA) network.
View Article and Find Full Text PDFAngew Chem Int Ed Engl
September 2025
State Key Laboratory of Functional Crystals and Devices, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, 350002, P.R. China.
Chiral metal halide perovskites (CMHPs) are a promising class of chiroptical materials with significant potential applications in chiral-optoelectronic and chiral-spintronic devices. However, their chirality induction generally stems from the incorporation of chiral ligands, which constitutes compositional diversity and functional versatility. Herein, we report a significant chiral expression resulting from two distinct mechanisms: chirality transfer induced by chiral organic cations and mirror symmetry breaking driven by stereochemically active lone pairs, both contributing to controlled chirality induction.
View Article and Find Full Text PDF